Non-Hodgkin lymphoma overview
You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in non-Hodgkin lymphoma with a commitment to meet your unique needs.
Why choose SCCA?
- Experts in non-Hodgkin lymphoma
Your SCCA medical oncologist, radiation oncologist and pathologist specialize in identifying your specific type, subtype and stage of lymphoma and providing a combination of advanced treatments tailored to you.
- New FDA-approved CAR T-cell therapies
SCCA is one of the first cancer centers in the nation to offer both FDA-approved cellular immunotherapies for non-Hodgkin lymphoma. Tisagenlecleucel, known as the brand name Kymriah®, and axicabtagene ciloleucel (axi-cel), known by the brand name Yescarta®, are CAR T-cell therapies available only at certified treatment centers.
- Bone marrow transplant for lymphoma
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We pioneered bone marrow transplants and have performed more than any other institution in the world.
- A national leader in cancer care
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
- NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.
“We’re lucky to have Seattle Cancer Care Alliance (SCCA) in our backyard,” said Scott Lundberg, a survivor of non-Hodgkin lymphoma (NHL). Scott is a plaintiff’s personal injury lawyer who talks to many doctors in the course of his work. He is also a long-distance athlete whose strength and endurance proved invaluable during cancer treatment.
Karen Allen will tell you that she’s a married, middle aged, middle income, mother of two. Her friends might tell you she’s also a biker chick. What you won’t readily know from either perspective is that she’s been faced with cancer — not once, but twice.
The day after Bellevue firefighter Eric Rickert completed the challenging Scott Firefighter Stairclimb in 2015, he began feeling unusual abdominal pain. He hoped it was just a stomach flu, but the sharp, cramping aches lasted for days. After weeks of seemingly endless tests and doctor appointments, Eric received life-changing news: He had stage 4 mantle cell lymphoma (MCL).
After experiencing back pain for years, King County Superior Court Judge Mike Heavey was diagnosed with non-Hodgkin lymphoma. He was treated at SCCA and since being in remission has taken up hiking with friends, including multiple climbs to the top of Mt. Rainier.
People with lymphoma have better hope of a cure and long-term survival than ever. Based on the specific features of your disease, your team may recommend watchful waiting, chemotherapy, radiation therapy, targeted therapy, immunotherapy or bone marrow transplant, all available at SCCA.
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in non-Hodgkin lymphoma clinical studies not available everywhere.